Topic Hub
4 educational articles in the WomenRx archive. This archive is being reviewed before search indexing.
Explore
Showing 4 of 4 clinical reviews.
Wegovy is FDA-approved for adults but rarely studied in women 65+. Learn what the evidence says about safety, dosing, muscle loss, and bone health in older women.
Read clinical reviewHow semaglutide 2.4 mg (Wegovy) use in girls under 12 transitions to adult women's care, including dosing, puberty, pregnancy safety, and long-term planning.
Read clinical reviewHow semaglutide 2.4 mg affects school performance, physical activity, and daily routines for adolescent girls ages 12 to 17. Clinician-reviewed guidance.
Read clinical reviewHow Wegovy (semaglutide 2.4 mg) affects older women's activity levels, fall risk, muscle loss, and daily function. Clinician-reviewed guidance for women 65+.
Read clinical review